Compare CACI & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CACI | FMS |
|---|---|---|
| Founded | 1962 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | EDP Services | Misc Health and Biotechnology Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 13.5B |
| IPO Year | 1979 | 1996 |
| Metric | CACI | FMS |
|---|---|---|
| Price | $553.18 | $23.50 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 14 | 2 |
| Target Price | ★ $616.50 | $30.00 |
| AVG Volume (30 Days) | 252.1K | ★ 470.2K |
| Earning Date | 01-21-2026 | 11-04-2025 |
| Dividend Yield | N/A | ★ 2.42% |
| EPS Growth | ★ 12.06 | 8.62 |
| EPS | ★ 22.62 | 2.86 |
| Revenue | $8,858,558,000.00 | ★ $23,046,819,198.00 |
| Revenue This Year | $10.71 | $2.12 |
| Revenue Next Year | $6.15 | $2.92 |
| P/E Ratio | $24.79 | ★ $16.02 |
| Revenue Growth | ★ 12.61 | 2.10 |
| 52 Week Low | $318.60 | $22.05 |
| 52 Week High | $632.77 | $30.46 |
| Indicator | CACI | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 33.20 | 44.98 |
| Support Level | $554.01 | $22.63 |
| Resistance Level | $566.00 | $23.88 |
| Average True Range (ATR) | 17.63 | 0.30 |
| MACD | -7.41 | 0.12 |
| Stochastic Oscillator | 2.70 | 68.63 |
CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.